Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
31.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
SWOG/NRG S1914: Randomized phase III trial of induction/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC.
James Moon, Jhanelle E. Gray, Rojano Kashani, Jessica R. Bauman et al.
Citations
10 citations
Journal
Journal of Clinical Oncology
Topics
Health Systems, Economic Evaluations, Quality of Life
Field-Weighted Citation Impact (FWCI)
31.31
article
SWOG/NRG S1914: Randomized phase III trial of induction/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC.
James Moon, Jhanelle E. Gray, Rojano Kashani, Jessica R. Bauman, Apar Kishor Ganti, Chen Hu, Jeffrey D. Bradley, Paul J. Hesketh, Megan E. Daly, Mary W. Redman, Arta M. Monjazeb, Josephine Feliciano, Karen Kelly, Conor Steuer, Kimberly Ku, Adedayo A. Onitilo, Charles B Simone, Ming-Hui Hsieh, Jieling Miao
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(16_suppl)
Institutions
Fox Chase Cancer Center (US), Memorial Sloan Kettering Cancer Center (US), Emory University (US), Moffitt Cancer Center (US), Fred Hutch Cancer Center (US), Cancer Research And Biostatistics (US), Lahey Medical Center (US), New York Proton Center (US), University Hospitals Seidman Cancer Center (US), Illinois CancerCare (US), University of California Davis Medical Center (US), UC Davis Health (US), NRG Oncology (US), Sidney Kimmel Comprehensive Cancer Center (US), UC Davis Comprehensive Cancer Center, Case Western Reserve University (US), University of Nebraska Medical Center (US), University of Pennsylvania (US), University of California, Davis (US)
OpenAlex Percentile
Openalex Percentile: Top 0%
Topics
Health Systems, Economic Evaluations, Quality of Life